DPT Meeting: Panel 1 – Protocol Objectives & Eligibility PANEL Discussion 1: Protocol Objectives and Eligibility Moderators: Abby Bronson, Scott Berry Panelists: Joanne Donovan, MD, PhD, Catabasis Pharmaceuticals Michael Panzara, MD, MPH, Wave Life Sciences Hank Mayer, MD, Children’s Hospital of Philadelphia Paula Clemens, MD, University of Pittsburgh Gretchen Egner, Parent/Advocate 2019 Duchenne Platform Trial Stakeholder Meeting,Conferences & Meetings 6 years ago You may also like Stronger Together: Empowering Families Through Community, Care, and Research – 2025 PPMD Annual Conference 3 weeks ago 2025 PPMD Annual Conference,Conferences & Meetings A New Era of Steroids, Endocrinology & Emergency Care – 2025 PPMD Annual Conference 3 weeks ago 2025 PPMD Annual Conference,Conferences & Meetings Opening Session: A New Era in Duchenne & Becker Muscular Dystrophy – 2025 PPMD Annual Conference 3 weeks ago 2025 PPMD Annual Conference,Conferences & Meetings The Impact of Diagnosis: Managing Family Dynamics – 2025 PPMD Annual Conference 3 weeks ago 2025 PPMD Annual Conference,Conferences & Meetings Exploring the Landscape of Gene Therapy – 2025 PPMD Annual Conference 3 weeks ago 2025 PPMD Annual Conference,Conferences & Meetings Trials & Treatments: Making Decisions that are Right for You – 2025 PPMD Annual Conference 3 weeks ago 2025 PPMD Annual Conference,Conferences & Meetings Building Friendships & Self Advocacy Skills – 2025 PPMD Annual Conference 3 weeks ago 2025 PPMD Annual Conference,Conferences & Meetings Keynote Address: Meeting the Challenge of Rare Disease – 2025 PPMD Annual Conference 3 weeks ago 2025 PPMD Annual Conference,Conferences & Meetings 123…28»Page 1 of 28